Mr. Jiang Lei is the rotating Co-Chairperson and Chief Marketing Officer of CEC, Chairperson of the board of directors of Shanghai MicroPort
Medical (Group) Co., Ltd. and the Chief Executive Officer of MicroPort Scientific (Shanghai) Co., Ltd.. Mr. Jiang has over 27 years of experience in
pharmaceutical and medical device industry.
From 1998 to 2006, Mr. Jiang worked in Mitsubishi Chemical in Japan and Abbott Medical Vascular Intervention Department. He joined the Microport Coronary Artery Marketing Department in 2006. In 2010, Mr. Jiang was appointed as the group's national coronary product sales director. In 2019, Mr. Jiang was appointed as advanced vice president of national coronary artery marketing. In 2020, Mr. Jiang was appointed as Senior Vice President of National Marketing. In 2021, Mr. Jiang was appointed as the President of Shanghai MicroPort Medical (Group) Co., Ltd. In December 2022, Mr. Jiang was appointed as the Chairman of the board of directors of Shanghai MicroPort Medical (Group) Co., Ltd..
Mr. Jiang graduated from Nanjing Medical University in 1998 and obtained an EMBA degree from Shanghai Jiaotong University in 2020.